GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,495.00
arrow_upward
+1.42%(+35.00) 1D
Aug 28, 2:18:09 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,460.00
High
₹2,499.80
Low
₹2,431.70
Mkt. cap
704.15B
Avg. vol.
0.00
Volume
466.84K
Dividend
0.20%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
51.73
52-wk high
₹2,499.80
52-wk low
₹1,792.60
EPS
₹48.23
Shares outstanding
0.00
No. of employees
14K
Open
₹2,460.00
High
₹2,499.80
Low
₹2,431.70
Mkt. cap
704.15B
Avg. vol.
0.00
Volume
466.84K
Dividend
0.20%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
51.73
52-wk high
₹2,499.80
52-wk low
₹1,792.60
EPS
₹48.23
Shares outstanding
0.00
No. of employees
14K
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees14.3K
FoundedNov 18, 1977
Headquarters-
SectorPharmaceutical industry
Websiteglenmarkpharma.com
AI content may include mistakes. Learn more